STAT6, NF-κB and C/EBP in CD23 expression and IgE production

International Immunology

Volumn 10, Issue 10, 1998, Pages 1529-1538

  Tinnell, Sheri B ^a   Jacobs Helber, Sarah M ^b   Sterneck, Esta ^c   Sawyer, Stephen T ^b   Conrad, Daniel H ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

C EBP; CD23; Cytokine; FcR; NF B; STAT6; Transcription factors

Indexed keywords

BINDING PROTEIN; CD23 ANTIGEN; CD40 ANTIGEN; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 4; STAT3 PROTEIN; STAT5 PROTEIN; STAT6 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; CCAAT ENHANCER BINDING PROTEIN; CD40 LIGAND; DNA BINDING PROTEIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; MEMBRANE PROTEIN; NUCLEAR PROTEIN; STAT6 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; IMMUNOBLOTTING; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CELL NUCLEUS; CYTOLOGY; DRUG EFFECT; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; B-LYMPHOCYTES; CCAAT-ENHANCER-BINDING PROTEINS; CD40 LIGAND; CELL NUCLEUS; CELLS, CULTURED; DNA-BINDING PROTEINS; IMMUNOGLOBULIN E; INTERLEUKIN-2; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); RECEPTORS, IGE; STAT6 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 0031593856     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/10.10.1529     Document Type: Article

References (69)

1. Lee, W. T. and Conrad, D. H. 1985. The murine lymphocyte receptor for IgE III. Use of chemical cross-linking reagents to further characterize the B lymphocyte Fc epsilon receptor. J. Immunol. 134:518.
2. Sutton, B. J. and Gould, H. J. 1993. The human IgE network. Nature 366:421.
3. Yokota, A., Kikutani, H., Tanaka, T., Sato, R., Barsumian, E. L., Suemura, M. and Kishimoto, T. 1988. Two species of human Fee receptor II (FcεRII/CD23): tissue-specific and IL-4-specific regulation of gene expression. Cell 55:611.
4. Conrad, D. H. 1990. FCεRII/CD23: the low affinity receptor for IgE. Ann. Rev. Immunol. 8:623.
5. Coffman, R. L., Ohara, J., Bond, M., Carty, J., Zlotnik, A. and Paul, W. E. 1986. B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. J. Immunol. 136:4538.
6. Conrad, D. H., Keegan, A. D., Kalli, K. R., Van-Dusen, R., Rao, M. and Levine, A. D. 1988. Superinduction of low affinity IgE receptors on murine B lymphocytes by lipopolysaccharide and IL-4. J. Immunol. 141:1091.
7. Keegan, A. D., Snapper, C. M., VanDusen, R., Paul, W. E. and Conrad, D. H. 1989. Superinduction of the murine B cell FcεRII by T helper cell clones. Role of interleukin-4. J. Immunol. 142:3868.
8. Purkerson, J. and Isakson, P. 1992. A two-signal model for regulation of immunoglobulin isotype switching. FASEB J. 6:3245.
9. Clark, E. A. and Ledbetter, J. A. 1994. How B and T cells talk to each other. Nature 367:425.
10. Richards, M. L. and Katz, D. H. 1997. Analysis of the promoter elements necessary for IL-4 and anti-CD40 antibody induction of murine FcεRII (CD23) - comparison with the germline ε promoter. J. Immunol. 158:263.
11. Conrad, D. H., Waldschmidt, T. J., Lee, W. T., Rao, M., Keegan, A. D., Noelle, R. J., Lynch, R. G. and Kehry, M. R. 1987. Effect of B cell stimulatory factor-1 (interleukin 4) on Fcε and Fcγ receptor expression on murine B lymphocytes and B cell lines. J. Immunol. 139:2290.
12. Gordon, J., Katira, A., Strain, A. J. and Gillis, S. 1991. Inhibition of interleukin 4-promoted CD23 production in human B lymphocytes by transforming growth factor-β, interferons or anti-CD19 antibody is overriden on engaging CD40. Eur. J. Immunol. 21:1917.
13. Armitage, R. J., Fanslow, W. C., Strockbine, L., Sato, T. A. ,Clifford, K. N., Macduff, B. M., Anderson, D. M., Gimpel, S. D., Davis-Smith, T., Maliszewski, C. R., Clark, E. A., Smith, C. A., Grabstein. K. H., Cosman, D. and Spriggs, M. K. 1992. Molecular and biological characterization of a murine ligand for CD40. Nature 357:80.
14. Keegan, A., Nelms, K. and Paul, W. E. 1994. The IL-4 receptor-signaling mechanisms. Adv. Exp. Med. Biol. 365:211.
15. Paul, W. E. 1991. Interleukin-4: a prototypic immunoregulatory lymphokine Leukemia & Lymphoma 77: 1859.
16. Kondo, M., Takeshita, T., Ishii, N., Nakamura, M., Watanabe, S., Aral, K. and Sugamura, K. 1993. Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science 262:1874.
17. Russell, S. M., Keegan, A. D., Harada, N., Nakamura, Y., Noguchi, M., Leland, P., Friedmann, M. C., Miyajima, A., Puri, R. K., Paul, W. E. and Leonard, W. J. 1993. Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. Science 262:1880.
18. Keegan, A. D., Nelms, K., White, M., Wang, L.-M., Pierce, J. H. and Paul, W. E. 1994. An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell 76:811.
19. Pernis, A., Witthuhn, B., Keegan, A. D., Nelms, K., Garfein, E., Ihle, J. N., Paul, W. E., Pierce, J. H. and Rothman, P. 1995. Interleukin-4 signals through two related pathways. Proc. Natl Acad. Sci. USA 92:7971.
20. Quelle, F. W., Shimoda, K., Thierfelder, W., Fischer, C., Kim, A., Ruben, S. M., Cleveland, J. L., Pierce, J. H., Keegan. A. D., Nelms, K., Paul, W. E. and Ihle, J. N. 1995. Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol. Cell. Biol. 15:3336.
21. Malabarba, M. G., Kirken, R. A., Rui, H., Koettnitz, K., Kawamura, M., O'Shea, J. J., Kalthoff, F. S. and Farrar. W. L. 1995. Activation of JAK3, but not JAK1, is critical to interleukin-4 (IL4) stimulated proliferation and requires a membrane-proximal region of IL4 receptor α. J. Biol. Chem. 270:9630.
22. Ryan, J. J., McReynolds, L. J., Keegan, A., Wang, L. H., Garfein, E., Rothman, P., Nelms, K. and Paul. W. E. Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. Immunity 4:123.
23. Ihle, J. N. and Kerr, I. M. 1995. Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet. 11:69.
24. Kaplan, M. H., Schindler, U., Smiley, S. T. and Grusby, M. J. 1996. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4:313.
25. Shimoda, K., van Deursen, J., Sangster, M. Y., Sarawar, S. R., Carson, R. T., Tripp, R. A., Chu, C., Quelle, F. W., Nosaka, T., Vignali, D. A. A., Doherty, P. C., Grosveld, G., Paul, W. E. and Ihle, J. N. 1996. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380:630.
26. Takeda, K., Tanaka, T., Shi, W., Matsumoto, M., Minami, M., Kashiwamura, S., Nakanishi, K., Yoshida, N., Kishimoto, T. and Akira, S. 1996. Essential role of Stat6 in IL-4 signalling. Nature 380:627.
27. Baeuerle, P. A. and Henkel, T. 1994. Function and activation of NF-kappaB in the immune system. Annu. Rev. Immunol. 12:141.
28. Berberich, I. Shu, G. L. and Clark, E. A. 1994. Cross-linking CD40 on B cells rapidly activates nuclear factor-kappaB. J. Immunol. 153:4357.
29. Verma, I. M., Stevenson, J. K., Schwarz, E. M. Antwerp, D. V. and Miyamoto, S. 1995. Rel-NF-kB/lkB family: intimate tales of association and dissociation. EMBO J. 9:2723.
30. Baeuerle, P. A. and Baltimore, D. 1996. NF-kappaB: ten years after. Cell 87:13.
31. Francis, D. A., Karras, J. G., Ke, X. Y., Sen, R. and Rothstein, T. L. 1995. Induction of the transcription factors NF-kappaB, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int. Immunol. 7:151.
32. Berberich, I., Shu, G., Siebelt, F., Woodgett, J. R., Kyriakis, J. M. and Clark, E. A. 1996. Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases. EMBO J. 15:92.
33. Hanissian, S. H. and Geha, R. S. 1997. Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells. Immunity 6:379.
34. Karras, J. G., Wang, Z., Huo, L., Frank, D. A. and Rothstein, T. L. 1997. Induction of STAT protein signaling through the CD40 receptor in B lymphocytes: distinct STAT activation following surface Ig and CD40 receptor engagement. J. Immunol. 159:4350.
35. Cooper, C. L. ,Berrier, A. L., Roman, C. and Calame, K. L. 1994. Limited expression of C/EBP family proteins during B lymphocyte development (negative regulator Ig/EBP predominates early and activator NK-IL-6 is induced later). J. Immunol. 153:5049.
36. Johnson, P. F. and Williams, S. C. 1994. CCAAT/enhancer binding (C/EBP) proteins. In Tronche, F. and Yaniv, M., eds, Transcriptional Regulation of Liver-Specific Genes, p. 231. R. G. Landes, Austin, TX.
37. Stein, B., Cogswell, P. C. and Baldwin A. S. 1995. Functional and physical associations between NF-kappaB and C/EBP family members: a Rel domain-bZIP interaction. Mol. Cell. Biol. 1993:3964.
38. Lee, Y. H., Williams, S. C., Baer, M., Sterneck, E., Gonzalez, F. J. and Johnson, P. F. 1997. The ability of C/EBP beta but not C/EBP alpha to synergize with an Sp1 protein is specified by the leucine zipper and activation domain. Mol. Cell. Biol. 17:2038.
39. Screpanti, I., Musiani, P., Bellavia, D., Cappelletti, M., Aiello, F. B., Maroder, M., Frati, L., Modesti, A., Gulino, A. and Poli, V. 1996. Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBP beta-deficient mice. J. Exp. Med. 184:1561.
40. Chen, X., Liu, W., Ambrosino, C., Ruocco, M. R., Poli, V., Romani, L., Quinto, I., Barbieri, S., Holmes, K. L., Venuta, S. and Scala, G. 1997. Impaired generation of bone marrow B lymphocytes in mice deficient in C/EBPbeta. Leukemia & Lymphoma 90:156.
41. Fattori, E., Sellitto, C., Cappelletti, M., Lazzaro, D., Bellavia, D., Screpanti, I., Gulino, A., Costantini, F. and Poli, V. 1995. Functional analysis of IL-6 and IL-6DBP/C/EBP beta by gene targeting. Ann. NY Acad. Sci. 762:262.
42. Akira, S., Yoshida, K., Tanaka, T., Taga, T., and Kishimoto, T. 1995. Targeted disruption of the IL-6 related genes: gp130 and NF-IL-6. Immunol. Rev. 148:221.
43. Delphin, S. and Stavnezer, J. 1995. Characterization of an interleukin 4 (IL-4) responsive region in the immunoglobulin heavy chain germline ε promoter: regulation by NF-IL-4, a C/EBP family member and NF-kappaB/p50. J Exp. Med. 181:181.
44. Sterneck, E., Tessarollo, L. and Johnson, P. F. 1997. An essential role for C/EBPbeta in female reproduction. Genes Dev. 11:2153.
45. Fanslow, W. C., Srinivasan, S., Paxton, R., Gibson, M. G., Spriggs, M. K. and Armitage, R. J. 1994. Structural characteristics of CD40 ligand that determine biological function [review]. Semin. Immunol. 6:267.
46. Unkeless, J. C. 1979. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150:580.
47. Schreiber, E., Matthias, P., Muller, M. M. and Schaffner, W. 1989. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17:6419.
48. Bartlett, W. C., Kelly, A. E., Johnson, C. M. and Conrad, D. H. 1995. Analysis of murine soluble FcεRII: sites of cleavage and requirements for dual affinity interaction with IgE. J. Immunol. 154:4240.
49. DeFranco, A. L., Raveche, E. S., Asofsky, R. and Paul, W. E. 1982. Frequency of B lymphocytes responsive to anti-immunoglobulin. J. Exp. Med. 155:1523.
50. Campbell, K. A., Lees, A., Finkelrnan, F. D. and Conrad, D. H. 1992. Co-crosslinking FcεRII/CD23 with B cell surface immunoglobulin modulates B cell activation. Eur. J. Immunol. 22:2107.
51. Jacobs-Helber, S. M., Penta, K., Sun, Z., Lawson, A. and Sawyer, S. T. 1997. Distinct signaling from stem cell factor and erythropoietin in HCD57 cells. J. Biol. Chem. 272:6850.
52. Harbury, P. B., Kim, P. S. and Alper, T. 1994. Crystal structure of an isoleucine-zipper trimer. Nature 371:80.
53. McGrew, J. T., Leiske, D., Dell, B., Klinke, R., Krasts, D., Wee, S. F., Abbott, N., Armitage, R. and Harrington, K. 1997. Expression of trimeric CD40 ligand in Pichia pastoris: use of a rapid method to detect high-level expressing transformants. Gene 187:193.
54. Cho, S.-W. and Conrad, D. H. 1997. A new multivalent B cell activation model - anti-lgD bound to FcγRI: properties and comparison with CD40L-mediated activation. Int. Immunol. 9:239.
55. Rolling, C., Treton, D., Pellegrini, S., Galanaud, P. and Richard, Y. 1996. IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells. FEBS Lett. 393:53.
56. O'Shea, J. J. 1997. Jaks, STATs, cytokine signal transduction and immunoregulation: are we there yet? [published erratum appears in Immunity 1997, 7(3):following 444]. Immunity 7:1.
57. Messner, B., Stütz, A. M., Albrecht, B., Peiritsch, S. and Woisetschläger, M. 1997. Cooperation of binding sites for STAT6 and NFkappaB/rel in the IL-4-induced up-regulation of the human IgE germline promoter. J. Immunol. 159:3330.
58. Sha, W. C., Liou, H.-C., Tuomanen, E. I. and Baltimore, D. 1995. Targeted disruption of the p50 subunit of NF-kappaB leads to multifocal defects in immune responses. Cell 80:321.
59. H transcription, and Ig class switching. J. Immunol. 156:183.
60. Dierks, S. E., Campbell, K. A., Studer, E. J. and Conrad, D. H. 1994. Molecular mechanisms of murine FcεRII/CD23 regulation Mol. Immunol. 31:1181.
61. Stavnezer, J. 1996. Antibody class switching. Adv. Immunol. 61:79.
62. Delphin, S. and Stavnezer, J. 1995. Regulation of antibody class switching to IgE: Characterization of an IL-4-responsive region in the immunoglobulin heavy-chain germline ε promoter. Ann. NY Acad. Sci. 764:123.
63. Seidel, H. M., Milocco, L. H., Lamb, P., Darnell, J. E., Stein, R. B. and Rosen, J. 1995. Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc. Natl Acad. Sci. USA 92:3041.
64. Hsing, Y., Hostager, B. S. and Bishop, G. A. 1997. Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes. J. Immunol. 159:4898.
65. Cheng, G., Cleary, A. M., Ye, Z., Hong, D. I., Lederman, S. and Baltimore, D. 1995. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267:1494.
66. Ishida, T., Tojo, T., Aoki, T., Kobayash, N., Ohishi, T., Watanabe, T., Yamamoto, T. and Inoue, J. 1996. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc. Natl Acad. Sci. USA 93:9437.
67. Siepmann, K., Wohlleben, G. and Gray, D. 1996. CD40-mediated regulation of interleukin-4 signaling pathways in B lymphocytes. Eur. J. Immunol. 26:1544.
68. Ohmori, Y. and Hamilton, T. A. 1995. The interferon-stimulated response element and a kappa B site mediate synergistic induction of murine IP-10 gene transcription by IFN-gamma and TNF-alpha. J. Immunol. 154:5235.
69. Richards, M. L. and Katz, D. H. 1994. Regulation of the murine FcεRII (CD23) gene: functional characterization of an IL-4 enhancer element. J. Immunol. 152:3453.